Civic AI
Procurement intelligence
Federal contract award
NEW AWARD FOR BUMETANIDE TABLETS WITH EXELAN PHARMACEUTICALS, INC.. PERIOD OF PERFORMANCE IS MAY 30, 2026, TO MAY 29, 2027, WITH FOUR ONE-YEAR OPTIONS.
EXELAN PHARMACEUTICALS INC · Department of Veterans Affairs
- Value
- $0
- Start
- May 30, 2026
- End
- —
- Action date
- Mar 18, 2026
- PIID
- 36E79726D0017
- Status
- active
- NAICS
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- Place of performance
- —
- Award type
- —
Description
NEW AWARD FOR BUMETANIDE TABLETS WITH EXELAN PHARMACEUTICALS, INC.. PERIOD OF PERFORMANCE IS MAY 30, 2026, TO MAY 29, 2027, WITH FOUR ONE-YEAR OPTIONS.
Need modifications, related awards, and vendor peers? Open the full award workspace.